首页>
外国专利>
HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES
HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES
展开▼
机译：旨在通过肠胃外给药治疗或预防细菌性疾病的混合型抗菌剂恶唑烷酮-喹诺酮
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: group of inventions refers to medicine and can be used for treating or preventing bacterial diseases in a patient. For this purpose, an oxazolidinone-quinolone hybrid agent is injected parenterally. Also presented is a pharmaceutical composition, a method of treating, using the hybrid agent oxazolidinone-quinolone.;EFFECT: group of inventions provides parenteral treatment or prevention of intestinal diseases caused by gram-positive bacteria.;19 cl, 2 tbl, 2 ex
展开▼
机译：领域：药物：发明组是指药物，可用于治疗或预防患者的细菌性疾病。为此目的，肠胃外注射恶唑烷酮-喹诺酮杂合剂。还提出了一种药物组合物，一种使用杂种恶唑烷酮-喹诺酮的治疗方法。效果：本发明组提供肠胃外治疗或预防由革兰氏阳性细菌引起的肠道疾病。19 cl，2 tbl，2 ex
展开▼
